ArticleVaccines2024

Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine as the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical Trial.

Yawen Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.